Global Investment In Life Science Data Infrastructure Continues To Accelerate

The global data acquisition market is projected to reach USD 2.8 billion by 2028, according to MarketsandMarkets, driven by expanding demand for high-resolution signal recording across pharmaceutical, biomedical, and academic research sectors. The growth reflects a broader shift within the life sciences toward digitised experimental workflows, where researchers increasingly require integrated hardware and software systems capable of capturing, processing, and analysing physiological signals in real time. A 2025 report from Grand View Research noted that laboratory automation and digital data capture have become central to reducing time-to-publication in peer-reviewed research, with institutions prioritising platforms that streamline the path from raw signal to publishable analysis.

Within this landscape, the convergence of analog-to-digital hardware with cloud-enabled analysis software has redefined what researchers expect from a data acquisition system. Where previous generations of laboratory equipment required significant manual configuration and post-hoc data processing, modern platforms now offer real-time visualisation, automated event detection, and seamless integration with downstream statistical tools. This evolution has been particularly pronounced in physiology and pharmacology, where multi-channel recording from human and animal subjects demands both precision and flexibility. Companies such as ADInstruments, whose PowerLab and LabChart platforms have accumulated over 50,000 citations in peer-reviewed journals since the company's founding in 1986, exemplify the category of purpose-built data acquisition device that has become standard infrastructure in university and commercial research laboratories worldwide.

The education sector has further amplified demand for accessible data acquisition technology, with universities seeking tools that bridge the gap between theoretical instruction and hands-on experimentation. The shift to hybrid and remote learning models accelerated adoption of cloud-based laboratory platforms, enabling students to interact with real physiological data outside traditional lab settings. Institutions across North America, Europe, and Australasia have invested in integrated teaching solutions that pair physical sensor hardware with digital lesson delivery, a trend that has expanded the addressable market for life science DAQ providers well beyond their traditional research base.

As funding bodies in the United States, European Union, and Asia-Pacific continue to increase allocations toward biomedical and translational research, the infrastructure layer supporting that work - from signal acquisition through to data management - is expected to remain a priority investment category through the remainder of the decade.

© Scoop Media